FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1489183668> ?p ?o ?g. }

• W1489183668 endingPage "284" @default.
• W1489183668 startingPage "283" @default.
• W1489183668 abstract "The human organic cation transporter, OCT1 (SLC22A1), a member of the SLC22 family, was first cloned in 1997.1 Since then OCT1 has been characterized as a major drug transporter in the liver, transporting important pharmacologic agents including the anti-diabetic drug, metformin and the anti-cancer drug, oxaliplatin. Genetic polymorphisms of OCT1 have been associated with variation in the disposition and response to drugs such as codeine2 and metformin,3 and with variation in serum levels of various metabolites (http://www.genome.gov/gwastudies/). Initial studies in Oct1−/− mice showed that deletion of Oct1 resulted in no observable physiologic changes.Our recent report contradicts these initial findings, and suggests that OCT1 has an important physiologic role beyond xenobiotic disposition, in mammals. Notably, we found that OCT1 is a high capacity thiamine transporter, and as such plays an important role in carbohydrate and lipid metabolism in hepatocytes.3 Our findings were based on integrated experimental approaches using cells, tissues, mouse models, metabolomic methods, and various molecular approaches to characterize the endogenous role of OCT1 including its principal substrate.3A key observation, that Oct1 deficiency alleviated hepatic steatosis in leptin deficient mice, inspired our further investigations. Our discovery (using metabolomic and isotopic uptake methods) that thiamine is the principal endogenous substrate of OCT1 provided the rationale for the reduced hepatic steatosis in the Oct1−/− mice. In particular, the thiamine derivative, thiamine pyrophosphate (TPP), is crucial for converting pyruvate to acetyl-CoA for glucose oxidative phosphorylation (ATP production) and fatty acid synthesis. The “short fall” in glycolytic energy production caused by OCT1 disruption in the knockout mice triggered increases in fatty acid oxidation to compensate for the energy requirement of the cell (Fig. 1). The dual effects caused by OCT1 deficiency (reduced glucose oxidation and increased β-oxidation) modulated the energy flow in the hepatocytes. Figure 1.The physiological role of OCT1 in the liver. Thiamine enters hepatocytes through OCT1. Deletion or inhibition of OCT1 reduces thiamine and TPP levels [1] and hence reduces glucose oxidation and de novo lipogenesis. The reduced ATP from glucose [2] activates ...Supporting the decreased glycolytic energy production, reductions in glucose oxidation rates, ATP levels and levels of key gluconeogenic enzymes, such as glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) (5) were observed in the livers of Oct1 deficient mice. Further, OCT1 expression was predominantly restricted to the peri-venous zone responsible for glycolysis and lipogenesis.3,4 Finally, our re-discovery that thiamine deficiency in rodents results in reduced hepatic steatosis implicates thiamine deficiency in the liver as the potential cause of the reduced hepatic steatosis in the Oct1 deficient mice.Beyond an understanding of basic physiology, our study has 3 critical implications. First, the findings suggest that there is a dose-response relationship for thiamine in terms of fat accumulation in the liver. The epidemic of beriberi that occurred in the early part of the 20th century was abated by thiamine supplementation in various products such as rice and bread. However our study raises an important point. Can thiamine supplementation be taken too far? Is too much thiamine a culprit for fatty liver disease? Clearly, the role of thiamine needs to be examined in light of the current epidemic in metabolic syndrome and diabetes. Second, our findings suggest that OCT1 represents an excellent target for the treatment of fatty liver disease and nonalcoholic steatohepatitis (NASH), an increasing health problem with limited therapeutic options.5 Developing small molecules or monoclonal antibodies against OCT1 would open a new window for NASH treatment.Finally, our study has important implications for the mechanisms of action of metformin, which is widely prescribed for the treatment of type 2 diabetes mellitus. How metformin acts has been the subject of numerous studies.6,7 Our study suggests that in addition to transporting metformin, OCT1 may serve as a target for metformin. In particular, parallel effects of metformin and Oct1 deficiency in mice were noted. For example, Oct1 deficiency and administration of metformin both result in reduced hepatic steatosis, and increased phosphorylation of AMPK and ACC. Moreover, we observed that metformin competitively inhibited OCT1-mediated thiamine uptake in transfected cells. In vivo, Oct1 deficiency resulted in substantially reduced intestinal and liver levels of thiamine; similarly, metformin treatment resulted in reduced intestinal and systemic plasma levels of thiamine and a trend toward reduced liver levels of thiamine. Modulation of thiamine levels by metformin (via OCT1 and perhaps other thiamine transporters) may be critically important in its beneficial effects on diabetes, hepatic steatosis, obesity and cancer.Collectively, the findings of our study present a compelling role for OCT1 in thiamine disposition, hepatic steatosis and energy production, and potentially in the mechanisms of metformin action (Fig. 1). However, in closing, several other points are worth mentioning. Firstly, exploration of the role of other endogenous substrates of OCT1, for example, serotonin, is needed. Secondly, studies of interactions between metformin and thiamine at transporters beyond OCT1 are needed to understand the role of metformin in thiamine disposition in other tissues. Finally, studies are clearly needed that differentiate the role of OCT1 in the cellular uptake of metformin and as a target for the drug." @default.
• W1489183668 created "2016-06-24" @default.
• W1489183668 creator A5012097154 @default.
• W1489183668 creator A5042220394 @default.
• W1489183668 creator A5081414468 @default.
• W1489183668 date "2015-02-01" @default.
• W1489183668 modified "2023-09-28" @default.
• W1489183668 title "OCT1 in hepatic steatosis and thiamine disposition" @default.
• W1489183668 cites W1920965755 @default.
• W1489183668 cites W1969416320 @default.
• W1489183668 cites W2035133162 @default.
• W1489183668 cites W2065612971 @default.
• W1489183668 cites W2084784711 @default.
• W1489183668 cites W2092340120 @default.
• W1489183668 cites W2156244027 @default.
• W1489183668 doi "https://doi.org/10.1080/15384101.2015.1006532" @default.
• W1489183668 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4353231" @default.
• W1489183668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25590948" @default.
• W1489183668 hasPublicationYear "2015" @default.
• W1489183668 type Work @default.
• W1489183668 sameAs 1489183668 @default.
• W1489183668 citedByCount "15" @default.
• W1489183668 countsByYear W14891836682016 @default.
• W1489183668 countsByYear W14891836682017 @default.
• W1489183668 countsByYear W14891836682018 @default.
• W1489183668 countsByYear W14891836682019 @default.
• W1489183668 countsByYear W14891836682020 @default.
• W1489183668 countsByYear W14891836682021 @default.
• W1489183668 countsByYear W14891836682022 @default.
• W1489183668 countsByYear W14891836682023 @default.
• W1489183668 crossrefType "journal-article" @default.
• W1489183668 hasAuthorship W1489183668A5012097154 @default.
• W1489183668 hasAuthorship W1489183668A5042220394 @default.
• W1489183668 hasAuthorship W1489183668A5081414468 @default.
• W1489183668 hasBestOaLocation W14891836681 @default.
• W1489183668 hasConcept C126322002 @default.
• W1489183668 hasConcept C134018914 @default.
• W1489183668 hasConcept C15744967 @default.
• W1489183668 hasConcept C2776175330 @default.
• W1489183668 hasConcept C2776203871 @default.
• W1489183668 hasConcept C2778772119 @default.
• W1489183668 hasConcept C2779134260 @default.
• W1489183668 hasConcept C38022665 @default.
• W1489183668 hasConcept C42407357 @default.
• W1489183668 hasConcept C55493867 @default.
• W1489183668 hasConcept C71924100 @default.
• W1489183668 hasConcept C77805123 @default.
• W1489183668 hasConcept C86803240 @default.
• W1489183668 hasConceptScore W1489183668C126322002 @default.
• W1489183668 hasConceptScore W1489183668C134018914 @default.
• W1489183668 hasConceptScore W1489183668C15744967 @default.
• W1489183668 hasConceptScore W1489183668C2776175330 @default.
• W1489183668 hasConceptScore W1489183668C2776203871 @default.
• W1489183668 hasConceptScore W1489183668C2778772119 @default.
• W1489183668 hasConceptScore W1489183668C2779134260 @default.
• W1489183668 hasConceptScore W1489183668C38022665 @default.
• W1489183668 hasConceptScore W1489183668C42407357 @default.
• W1489183668 hasConceptScore W1489183668C55493867 @default.
• W1489183668 hasConceptScore W1489183668C71924100 @default.
• W1489183668 hasConceptScore W1489183668C77805123 @default.
• W1489183668 hasConceptScore W1489183668C86803240 @default.
• W1489183668 hasIssue "3" @default.
• W1489183668 hasLocation W14891836681 @default.
• W1489183668 hasLocation W14891836682 @default.
• W1489183668 hasLocation W14891836683 @default.
• W1489183668 hasLocation W14891836684 @default.
• W1489183668 hasLocation W14891836685 @default.
• W1489183668 hasLocation W14891836686 @default.
• W1489183668 hasOpenAccess W1489183668 @default.
• W1489183668 hasPrimaryLocation W14891836681 @default.
• W1489183668 hasRelatedWork W1973843004 @default.
• W1489183668 hasRelatedWork W2026143540 @default.
• W1489183668 hasRelatedWork W2032775519 @default.
• W1489183668 hasRelatedWork W2083652468 @default.
• W1489183668 hasRelatedWork W2125534085 @default.
• W1489183668 hasRelatedWork W2135369758 @default.
• W1489183668 hasRelatedWork W2797640654 @default.
• W1489183668 hasRelatedWork W3158316884 @default.
• W1489183668 hasRelatedWork W4366987516 @default.
• W1489183668 hasRelatedWork W4382133235 @default.
• W1489183668 hasVolume "14" @default.
• W1489183668 isParatext "false" @default.
• W1489183668 isRetracted "false" @default.
• W1489183668 magId "1489183668" @default.
• W1489183668 workType "article" @default.